We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Healthcare Utilization and Costs after Receiving a Positive BRCA1/2 Result from a Genomic Screening Program.
- Authors
Hao, Jing; Hassen, Dina; Manickam, Kandamurugu; Murray, Michael F.; Hartzel, Dustin N.; Hu, Yirui; Liu, Kunpeng; Rahm, Alanna Kulchak; Williams, Marc S.; Lazzeri, Amanda; Buchanan, Adam; Sturm, Amy; Snyder, Susan R.
- Abstract
Population genomic screening has been demonstrated to detect at-risk individuals who would not be clinically identified otherwise. However, there are concerns about the increased utilization of unnecessary services and the associated increase in costs. The objectives of this study are twofold: (1) determine whether there is a difference in healthcare utilization and costs following disclosure of a pathogenic/likely pathogenic (P/LP) BRCA1/2 variant via a genomic screening program, and (2) measure the post-disclosure uptake of National Comprehensive Cancer Network (NCCN) guideline-recommended risk management. We retrospectively reviewed electronic health record (EHR) and billing data from a female population of BRCA1/2 P/LP variant carriers without a personal history of breast or ovarian cancer enrolled in Geisinger's MyCode genomic screening program with at least a one-year post-disclosure observation period. We identified 59 women for the study cohort out of 50,726 MyCode participants. We found no statistically significant differences in inpatient and outpatient utilization and average total costs between one-year pre- and one-year post-disclosure periods ($18,821 vs. $19,359, p = 0.76). During the first year post-disclosure, 49.2% of women had a genetic counseling visit, 45.8% had a mammography and 32.2% had an MRI. The uptake of mastectomy and oophorectomy was 3.5% and 11.8%, respectively, and 5% of patients received chemoprevention.
- Subjects
MEDICAL care costs; ELECTRONIC health records; GENETIC counseling; OVARIAN cancer
- Publication
Journal of Personalized Medicine, 2020, Vol 10, Issue 1, p7
- ISSN
2075-4426
- Publication type
Article
- DOI
10.3390/jpm10010007